Chronic β-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 3, 2004, Pages 167-174

  Dostanic, Stevan ^a   Servant, Nicolas ^a   Wang, Chunlei ^a   Chalifour, Lorraine E ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Catecholamine infusion; Egr 1; Mice

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CASPASE 12; CASPASE 3; CASPASE 9; CATECHOLAMINE; CELL MARKER; CLUSTERIN; CYTOCHROME C; DOBUTAMINE; GLUCOSE REGULATED PROTEIN 78; ISOPRENALINE; ORCIPRENALINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXPERIMENTAL MOUSE; HEART FAILURE; IMMUNOBLOTTING; IN VIVO STUDY; INFUSION; MALE; MEASUREMENT; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BODY WEIGHT; CELL SURVIVAL; CLUSTERIN; DNA-BINDING PROTEINS; DOBUTAMINE; DRUG THERAPY, COMBINATION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION; GENES, BCL-2; GLYCOPROTEINS; IMMEDIATE-EARLY PROTEINS; INFUSION PUMPS; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MOLECULAR CHAPERONES; MYOCYTES, CARDIAC; ORCIPRENALINE; ORGAN SIZE; PHENYLEPHRINE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RNA; TRANSCRIPTION FACTORS;

EID: 2442522401     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-134     Document Type: Article

References (36)

1. Akao, M., O'Rourke, B., Techima, Y., Saharasayon, J., and Marban, E. 2003. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ. Res. 92: 186-194.
2. Bennett, M.R. 2002. Apoptosis in the cardiovascular system. Heart, 87: 480-487.
3. Bernstein, D. 2002. Cardiovascular and metabolic alterations in mice lacking β1- and β2-adrenergic receptors. Trends Cardio. Med. 12: 287-294.
4. i-dependent coupling to phosphatidylinositol 3′-kinase. Circ. Res. 87: 1172-1179.
5. Chruscinski, A.J., Rohrer, D.K., Schauble, E., Desai, K.H., Bernstein, D., and Kobilka, B.K. 1999. Targeted disruption of the beta2 adrenergic receptor gene. J. Biol. Chem. 274: 16 694 - 16 700.
6. Cohn, J.N., Levine, T.B., Olivari, M.T., Garberg, V., Lura, D., Francis, G.S., Simon, A.N., and Rector, T. 1984. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311: 819-823.
7. Colucci, W.S., Sawyer, D.B., Singh, K., and Communal, C. 2000. Adrenergic overload and apoptosis in heart failure: implications for therapy. J. Cardiac Failure, 6: 1-7.
8. Communal, C., Singh, K., Sawyer, D.B., and Colucci, W.S. 1999. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation, 100: 2210-2212.
9. DeBelle, I., Huan, R.-P., Fan, Y., Liu, C., Mercola, D., and Adamson, E.D. 1999. P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene, 18: 3633-3642.
10. DeBoer, R.A., van Vekldhuisen, D.J., van der Wijk, J., Brouwer, H.J., de Jonge, N., Cole, G.M., and Suurmeijer, A.J.H. 2000. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J. Cardiac Fail. 6: 330-337.
11. Engelhardt, S., Hein, L., Wisemann, F., and Lohse, M.J. 1999. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 96: 7059-7064.
12. Fortuno, M.A., Gonzalez, A., Ravassa, S., Lopez, B., and Diez, J. 2003. Clinical implications of apoptosis in hypertensive heart disease. Am. J. Physiol. 284: H1495-H1506.
13. Frustaci, A., Chimenti, C., Setoguchi, M., Guerra, S., Corsello, S., Crea, F., Leri, A., Kajstura, J., Anversa, P., and Maseri, A. 1999. Cell death in acromegalic cardiomyopathy. Circulation, 99: 1426-1434.
14. Gill, C., Mestril, R., and Samali, A. 2002. Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J. 16: 135-146.
15. Haider, N., Narula, N., and Narula, J. 2002. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J. Card. Failure, 8: S512-S517.
16. Hallahan, D.E., Dunophy, E., Virudachalam, S., Sukhatme, V.P., Kufe, D.W., and Wischelbaum, R.R. 1995. C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J. Biol. Chem. 270: 30 303-30 309.
17. Heon, S., Bernier, M., Servant, N., Dostanic, S., Wang, C., Kirby, G.M., Alpert, L., and Chalifour, L.E. 2003. Dexrazoxane does not protect against doxorubcin-induced damage in young rats. Am. J. Physiol. 285: H499-H506.
18. Jones, S.E., and Jomary, C. 2002. Clusterin. Int. J. Biochem. Cell Biol. 34: 427-431.
19. Liggett, S.B., Tepe, N.M., Lorenz, J.N., Jantz, T.D., Mitarai, S., Yatani, A., and Dorn, G.W. 2000. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation, 101: 1707-1714.
20. McConkey, D.J., and Nutt, L.K. 2001. Calcium flux measurements in apoptosis. Methods Cell Biol. 66: 229-246.
21. McLaughlin, L., Zhu, G., Mistry, M., Ley-Ebert, C., Stuart, W.D., Florio, C.J., Groen, P.A., Witt, S.A., Kimball, T.R., Witte, D.P., Harmony, J.A., and Aronow, B.J. 2000. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Investig. 106: 1105-1113.
22. Milano, C.A., Allen, L.F., Rockman, H.A., Dolber, P.C., McMinn, T.R., Chien, K.R., Johnson, T.D., Bond, R.A., and Lefkowitz, R.J. 1994. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science (Washington, D.C.), 264: 582-586.
23. Muthukkumar, S., Nair, P., Sells, S.F., Maddiwar, N.G., Jacob, R.J., and Rangekar, V.M. 1995. Role of Egr-1 in thapsigargin-inducible apoptosis in the melanoma cell lines A375-C6. Mol. Cell. Biol. 15: 6262-6272.
24. Nakagawa, T., and Yuan, J. 2000. Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J. Cell. Biol. 150: 887-894.
25. Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F., Bello, B., Semigran, M., Biela-Masdeu, A., Dee, G., Israels, S., Ballester, M., Virmani, R., Saxena, S., and Kharbanda, S. 1999. Apoptosis in myocytes in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 96: 8144-8149.
26. Patil, C., and Walter, P. 2001. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Current Opin. Cell. Biol. 13: 349-356.
27. Qin, F., Rounds, N.K., Mao, W., Kawai, K., and Liang, C.S. 2001. Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets. Cardiovasc. Res. 51: 736-748.
28. Rao, R.V., Peel, A., Logvinova, A., delRio, G., Hermal, E., Yokota, T., Goldsmith, P.C., Ellerby, L.M., Ellerby, H.M., and Bredesen, D.E. 2002. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Letts. 514: 122-128.
29. Rohrer, D.K., Desai, K., Jasper, J., Stevens, M.E., Regula, Jr., D.P., Barsh, G.S., Berstein, D., and Kobilka, B.K. 1996. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl. Acad. Sci. U.S.A. 93: 7375-7380.
30. Saadane, N., Alpert, L., and Chalifour, L.E. 1999. Expression of immediate early genes, GATA-4, and Nkx2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br. J. Pharmacol. 127: 1165-1176.
31. Saadane, N., Alpert, L., and Chalifour, L.E. 2000. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1 deficient mice. Am. J. Physiol. 278: H796-H805.
32. Schubel, R.J., Bartling, B., Simm, A., Silber, R.-E., Drogaris, K., Darmer, D., and Holtz, D. 2002. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in human myocardium. J. Am. Coll. Card. 39: 481-488.
33. Steenbergen, C., Afshari, C.A., Petranka, J.G., Collins, J., Martin, K., Bennett, L., Haugen, A., Bushel, P., and Murphy,. E. 2003. Alteration in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am. J. Physiol. 284: H268-H276.
34. Treiman, M. 2002. Regulation of the endoplasmic reticulum calcium storage during the unfolded protein response - significance in tissue ischemia. Trends Cardio. Med. 12: 57-62.
35. Yasuda, M., and Chinnadurai, G. 2000. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1. Oncogene, 19: 2363-2367.
36. Zaugg, M., Xu, W., Lucchinetti, E., Shafiq, S.A., Jamali, N.Z., and Siddiqui, M.A. 2000. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation, 102: 344-350.